This NDC is on FDA's drug shortage list (posted Mar 23, 2018)

Product Information

KETOROLAC 60 MG/2 ML VIAL is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.6502 per ML under NDC 62332060125. Its NADAC has been published 180 times since Jun 14, 2023.

FDA first approved this application on Nov 2, 2022. Its Orange Book therapeutic-equivalence code is AP.

KETOROLAC 60 MG/2 ML VIAL

Ketorolac Tromethamine
$0.6502per ML

Strength

60 mg/2mL

NDC

62332060125

Classification

Generic

Dosage Form

INJECTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

11/18/2026

Active Ingredients

KETOROLAC TROMETHAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA214456

FDA Approved

11/2/2022

TE Code

AP

On Market Since

11/2/2022

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitor
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for KETOROLAC 60 MG/2 ML VIAL has been published 180 times since Jun 14, 2023, and over the history we have for it it has declined 5.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6502 per ML
All-time high$0.8748 (Jun 12, 2024)
All-time low$0.4543 (Feb 18, 2026)
52-week high$0.6502
52-week low$0.4543
Median price$0.6406
Average price$0.6442
Largest weekly change+18.1% (Jul 19, 2023)
Weeks tracked180
Tracking sinceJun 14, 2023

Price History

1W

+5.4%

1M

+17.7%

3M

+30.6%

6M

+26.6%

1Y

+19.5%

3Y

-8.7%

5Y

N/A

All

-5.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ketorolac Tromethamine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KETOROLAC 60 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 60 MG/2 ML VIAL, manufactured by Alembic Pharmaceuticals Inc., is $0.6502 per ML (NDC 62332060125), effective Nov 18, 2026.

How has the price of KETOROLAC 60 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for KETOROLAC 60 MG/2 ML VIAL has declined 5.1%. It has been tracked across 180 weekly CMS publications since Jun 14, 2023.

What are the highest and lowest recorded NADAC prices for KETOROLAC 60 MG/2 ML VIAL?

Since Jun 14, 2023, the NADAC for KETOROLAC 60 MG/2 ML VIAL has ranged from a low of $0.4543 (Feb 18, 2026) to a high of $0.8748 (Jun 12, 2024), with a median of $0.6406 per ML.

Are there cheaper alternatives to KETOROLAC 60 MG/2 ML VIAL?

No other NADAC-published product currently shares the active ingredient and strength of KETOROLAC 60 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures KETOROLAC 60 MG/2 ML VIAL?

KETOROLAC 60 MG/2 ML VIAL (NDC 62332060125) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.

Is KETOROLAC 60 MG/2 ML VIAL in shortage?

Yes — NDC 62332060125 is currently listed in FDA's drug shortage database (posted Mar 23, 2018).